315 related articles for article (PubMed ID: 22335254)
1. Pulmonary fungal infections.
Smith JA; Kauffman CA
Respirology; 2012 Aug; 17(6):913-26. PubMed ID: 22335254
[TBL] [Abstract][Full Text] [Related]
2. Frequency, diagnosis and management of fungal respiratory infections.
Hayes GE; Denning DW
Curr Opin Pulm Med; 2013 May; 19(3):259-65. PubMed ID: 23411576
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary aspergillosis: a clinical update.
Zmeili OS; Soubani AO
QJM; 2007 Jun; 100(6):317-34. PubMed ID: 17525130
[TBL] [Abstract][Full Text] [Related]
4. Changing strategies for the management of invasive fungal infections.
Rapp RP
Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
[TBL] [Abstract][Full Text] [Related]
5. Common and emerging fungal pulmonary infections.
Hsu LY; Ng ES; Koh LP
Infect Dis Clin North Am; 2010 Sep; 24(3):557-77. PubMed ID: 20674792
[TBL] [Abstract][Full Text] [Related]
6. [Acute invasive pulmonary aspergillosis in chronic lung disease--a review].
Ader F; Nseir S; Guery B; Tillie-Leblond I
Rev Mal Respir; 2006 Jun; 23(3 Suppl):6S11-6S20. PubMed ID: 16820744
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcal lung disease.
Shirley RM; Baddley JW
Curr Opin Pulm Med; 2009 May; 15(3):254-60. PubMed ID: 19352182
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary blastomycosis.
Bariola JR; Vyas KS
Semin Respir Crit Care Med; 2011 Dec; 32(6):745-53. PubMed ID: 22167402
[TBL] [Abstract][Full Text] [Related]
9. Changing epidemiology of systemic fungal infections.
Richardson M; Lass-Flörl C
Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary mucormycosis.
Hamilos G; Samonis G; Kontoyiannis DP
Semin Respir Crit Care Med; 2011 Dec; 32(6):693-702. PubMed ID: 22167397
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary aspergillosis: recent advances.
Thompson GR; Patterson TF
Semin Respir Crit Care Med; 2011 Dec; 32(6):673-81. PubMed ID: 22167395
[TBL] [Abstract][Full Text] [Related]
12. Changes in the epidemiological landscape of invasive mould infections and disease.
Lass-Flörl C; Cuenca-Estrella M
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i5-i11. PubMed ID: 28355462
[TBL] [Abstract][Full Text] [Related]
13. Management of fungal lung disease in the immunocompromised.
Islam A; Mody CH
Ther Adv Respir Dis; 2011 Oct; 5(5):305-24. PubMed ID: 21807757
[TBL] [Abstract][Full Text] [Related]
14. Invasive pulmonary aspergillosis complicating neoplastic disease.
Pursell KJ
Semin Respir Infect; 1992 Jun; 7(2):96-103. PubMed ID: 1439324
[TBL] [Abstract][Full Text] [Related]
15. The value of amphotericin B in the treatment of invasive fungal infections.
Klepser M
J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary cryptococcosis.
Brizendine KD; Baddley JW; Pappas PG
Semin Respir Crit Care Med; 2011 Dec; 32(6):727-34. PubMed ID: 22167400
[TBL] [Abstract][Full Text] [Related]
17. Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections.
Cornely OA
Infection; 2008 Aug; 36(4):296-313. PubMed ID: 18642109
[TBL] [Abstract][Full Text] [Related]
18. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Metcalf SC; Dockrell DH
J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
[TBL] [Abstract][Full Text] [Related]
19. Invasive mould infections in the ICU setting: complexities and solutions.
Bassetti M; Bouza E
J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
[TBL] [Abstract][Full Text] [Related]
20. Changing epidemiology of rare mould infections: implications for therapy.
Malani AN; Kauffman CA
Drugs; 2007; 67(13):1803-12. PubMed ID: 17722951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
